Multidisciplinary collaboration coupled with the use of multimodal strategies has enabled the tailoring of treatment plans based on the patient’s medical status and type of surgery.
This agent recently achieved an additional indication to reduce myocardial infarction, stroke, coronary revascularization, and cardiovascular death risk in adult patients with ASCVD.
Researchers suggest that measures aimed at improving mood could reduce inflammation and potentially provide an alternative treatment or one that works alongside inflammatory bowel disease medications.